Scientists develop broad-spectrum inhibitors of influenza virus

A team of researchers from The Scripps Research Institute (TSRI) and Janssen Research & Development (Janssen) has devised artificial peptide molecules that neutralize a broad range of influenza virus strains. Peptides are short chains of amino acids - like proteins but with smaller, simpler structures. These designed molecules have the potential to be developed into medicines that target influenza, which causes up to 500,000 deaths worldwide each year and costs Americans billions of dollars in sick days and lost productivity.

Mensmopolitan is a global news and entertainment expose providing a pleasurable flow of content fit for gentleman and lady, alike.

18d3877f0f6811b39525a6afe0693c1d